APO RESEARCH · REPORT
Thromboelastography (TEG) Machine
Thromboelastography (Thromboelastography) is a new blood viscoelastic detection system suitable for bedside detection. It uses whole blood samples to monitor the whole process of blood coagulation and fibrinolysis, which can well make up for the deficiency of traditional blood coagulation detection.
Product & engineering
Understand the product.
Thromboelastography (Thromboelastography) is a new blood viscoelastic detection system suitable for bedside detection. It uses whole blood samples to monitor the whole process of blood coagulation and fibrinolysis, which can well make up for the deficiency of traditional blood coagulation detection.
Thromboelastogram provides a general picture of coagulation function. It is an inspection item that can dynamically monitor the whole process of coagulation and fibrinolysis. It can completely describe the whole process of a blood sample from coagulation initiation, coagulation and dissolution, and help doctors quickly judge the patient's coagulation status (high coagulation, low coagulation and fibrinolytic hyperactivity) and analyze the causes.
It is of great value in clinical evaluation of coagulation function, guidance of component transfusion, prediction of thrombosis/bleeding risk and guidance of medication.
Selected research
Industry Research
Thromboelastography (TEG) Machine Industry Research Report 2026
Market perspective
Thromboelastography (Thromboelastography) is a new blood viscoelastic detection system suitable for bedside detection. It uses whole blood samples to monitor the whole process of blood coagulation and fibrinolysis, which can well make up for the deficiency of traditional blood coagulation detection.
Thromboelastogram provides a general picture of coagulation function. It is an inspection item that can dynamically monitor the whole process of coagulation and fibrinolysis. It can completely describe the whole process of a blood sample from coagulation initiation, coagulation and dissolution, and help doctors quickly judge the patient's coagulation status (high coagulation, low coagulation and fibrinolytic hyperactivity) and analyze the causes.
It is of great value in clinical evaluation of coagulation function, guidance of component transfusion, prediction of thrombosis/bleeding risk and guidance of medication.
Read the full market overview
Haemonetics, Werfenlife, Framar Hemologix SRL, Lepco Diagnostics, Sienco and so on are the main manufacturers of thromboelastography.The top five global manufacturers account for 77% of total sales.North America and Europe are the main production regions of thromboelastographs.North America accounts for 42% of the global production of thromboelastographs, ranking first in the world.Europe was next with 34 percent.North America is the world's largest consumer region of thromboelastograms, accounting for 39% of global sales.Europe was second with 21 percent.
Report Scope
This report quantifies the global Thromboelastography (TEG) Machine market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Thromboelastography (TEG) Machine Market by Company
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Framar Hemologix srl
Sienco
Thromboelastography (TEG) Machine Segment by Type
Single and Double Channel
Four Channels
Others
Thromboelastography (TEG) Machine Segment by Application
Hospitals
Maternal and Child Health Service
Laboratory
Others
Thromboelastography (TEG) Machine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thromboelastography (TEG) Machine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Thromboelastography (TEG) Machine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thromboelastography (TEG) Machine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Thromboelastography (TEG) Machine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Thromboelastography (TEG) Machine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Thromboelastography (TEG) Machine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single and Double Channel
- Four Channels
- Others
Applications
- Hospitals
- Maternal and Child Health Service
- Laboratory
- Others
Companies covered
- Haemonetics
- Lepu Technology
- Biomart
- Medcaptain
- Ud-bio
- Chongqing Nanfang
- WITEYE
- Render
- Guizhou Jinjiu Biotech
- Chongqing Dingrun
- Zhejiang Shengyu
- Bio-zircon
- WerfenLife
- Framar Hemologix srl
- Sienco
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Thromboelastography (TEG) Machine Market Size (2021-2032)
- 2.2.2 Global Thromboelastography (TEG) Machine Sales (2021-2032)
- 2.2.3 Global Thromboelastography (TEG) Machine Market Average Price (2021-2032)
- 2.3 Thromboelastography (TEG) Machine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single and Double Channel
- 2.3.3 Four Channels
- 2.3.4 Others
- 2.4 Thromboelastography (TEG) Machine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Maternal and Child Health Service
- 2.4.4 Laboratory
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Thromboelastography (TEG) Machine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Thromboelastography (TEG) Machine Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Thromboelastography (TEG) Machine Revenue of Manufacturers (2021-2026)
- 3.4 Global Thromboelastography (TEG) Machine Average Price by Manufacturers (2021-2026)
- 3.5 Global Thromboelastography (TEG) Machine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Thromboelastography (TEG) Machine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Thromboelastography (TEG) Machine, Product Type & Application
- 3.8 Global Manufacturers of Thromboelastography (TEG) Machine, Established Date
- 3.9 Global Thromboelastography (TEG) Machine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Haemonetics
- 4.1.1 Haemonetics Company Information
- 4.1.2 Haemonetics Business Overview
- 4.1.3 Haemonetics Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Haemonetics Thromboelastography (TEG) Machine Product Portfolio
- 4.1.5 Haemonetics Recent Developments
- 4.2 Lepu Technology
- 4.2.1 Lepu Technology Company Information
- 4.2.2 Lepu Technology Business Overview
- 4.2.3 Lepu Technology Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lepu Technology Thromboelastography (TEG) Machine Product Portfolio
- 4.2.5 Lepu Technology Recent Developments
- 4.3 Biomart
- 4.3.1 Biomart Company Information
- 4.3.2 Biomart Business Overview
- 4.3.3 Biomart Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biomart Thromboelastography (TEG) Machine Product Portfolio
- 4.3.5 Biomart Recent Developments
- 4.4 Medcaptain
- 4.4.1 Medcaptain Company Information
- 4.4.2 Medcaptain Business Overview
- 4.4.3 Medcaptain Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Medcaptain Thromboelastography (TEG) Machine Product Portfolio
- 4.4.5 Medcaptain Recent Developments
- 4.5 Ud-bio
- 4.5.1 Ud-bio Company Information
- 4.5.2 Ud-bio Business Overview
- 4.5.3 Ud-bio Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ud-bio Thromboelastography (TEG) Machine Product Portfolio
- 4.5.5 Ud-bio Recent Developments
- 4.6 Chongqing Nanfang
- 4.6.1 Chongqing Nanfang Company Information
- 4.6.2 Chongqing Nanfang Business Overview
- 4.6.3 Chongqing Nanfang Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chongqing Nanfang Thromboelastography (TEG) Machine Product Portfolio
- 4.6.5 Chongqing Nanfang Recent Developments
- 4.7 WITEYE
- 4.7.1 WITEYE Company Information
- 4.7.2 WITEYE Business Overview
- 4.7.3 WITEYE Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 WITEYE Thromboelastography (TEG) Machine Product Portfolio
- 4.7.5 WITEYE Recent Developments
- 4.8 Render
- 4.8.1 Render Company Information
- 4.8.2 Render Business Overview
- 4.8.3 Render Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Render Thromboelastography (TEG) Machine Product Portfolio
- 4.8.5 Render Recent Developments
- 4.9 Guizhou Jinjiu Biotech
- 4.9.1 Guizhou Jinjiu Biotech Company Information
- 4.9.2 Guizhou Jinjiu Biotech Business Overview
- 4.9.3 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Product Portfolio
- 4.9.5 Guizhou Jinjiu Biotech Recent Developments
- 4.10 Chongqing Dingrun
- 4.10.1 Chongqing Dingrun Company Information
- 4.10.2 Chongqing Dingrun Business Overview
- 4.10.3 Chongqing Dingrun Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Chongqing Dingrun Thromboelastography (TEG) Machine Product Portfolio
- 4.10.5 Chongqing Dingrun Recent Developments
- 4.11 Zhejiang Shengyu
- 4.11.1 Zhejiang Shengyu Company Information
- 4.11.2 Zhejiang Shengyu Business Overview
- 4.11.3 Zhejiang Shengyu Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zhejiang Shengyu Thromboelastography (TEG) Machine Product Portfolio
- 4.11.5 Zhejiang Shengyu Recent Developments
- 4.12 Bio-zircon
- 4.12.1 Bio-zircon Company Information
- 4.12.2 Bio-zircon Business Overview
- 4.12.3 Bio-zircon Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bio-zircon Thromboelastography (TEG) Machine Product Portfolio
- 4.12.5 Bio-zircon Recent Developments
- 4.13 WerfenLife
- 4.13.1 WerfenLife Company Information
- 4.13.2 WerfenLife Business Overview
- 4.13.3 WerfenLife Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 WerfenLife Thromboelastography (TEG) Machine Product Portfolio
- 4.13.5 WerfenLife Recent Developments
- 4.14 Framar Hemologix srl
- 4.14.1 Framar Hemologix srl Company Information
- 4.14.2 Framar Hemologix srl Business Overview
- 4.14.3 Framar Hemologix srl Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Framar Hemologix srl Thromboelastography (TEG) Machine Product Portfolio
- 4.14.5 Framar Hemologix srl Recent Developments
- 4.15 Sienco
- 4.15.1 Sienco Company Information
- 4.15.2 Sienco Business Overview
- 4.15.3 Sienco Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Sienco Thromboelastography (TEG) Machine Product Portfolio
- 4.15.5 Sienco Recent Developments
5 Global Thromboelastography (TEG) Machine Market Scenario by Region
- 5.1 Global Thromboelastography (TEG) Machine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Thromboelastography (TEG) Machine Sales by Region: 2021-2032
- 5.2.1 Global Thromboelastography (TEG) Machine Sales by Region: 2021-2026
- 5.2.2 Global Thromboelastography (TEG) Machine Sales by Region: 2027-2032
- 5.3 Global Thromboelastography (TEG) Machine Revenue by Region: 2021-2032
- 5.3.1 Global Thromboelastography (TEG) Machine Revenue by Region: 2021-2026
- 5.3.2 Global Thromboelastography (TEG) Machine Revenue by Region: 2027-2032
- 5.4 North America Thromboelastography (TEG) Machine Market Facts & Figures by Country
- 5.4.1 North America Thromboelastography (TEG) Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Thromboelastography (TEG) Machine Sales by Country (2021-2032)
- 5.4.3 North America Thromboelastography (TEG) Machine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Thromboelastography (TEG) Machine Market Facts & Figures by Country
- 5.5.1 Europe Thromboelastography (TEG) Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Thromboelastography (TEG) Machine Sales by Country (2021-2032)
- 5.5.3 Europe Thromboelastography (TEG) Machine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Thromboelastography (TEG) Machine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Thromboelastography (TEG) Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Thromboelastography (TEG) Machine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Thromboelastography (TEG) Machine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Thromboelastography (TEG) Machine Market Facts & Figures by Country
- 5.7.1 South America Thromboelastography (TEG) Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Thromboelastography (TEG) Machine Sales by Country (2021-2032)
- 5.7.3 South America Thromboelastography (TEG) Machine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Thromboelastography (TEG) Machine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Thromboelastography (TEG) Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Thromboelastography (TEG) Machine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Thromboelastography (TEG) Machine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Thromboelastography (TEG) Machine Sales by Type (2021-2032)
- 6.1.1 Global Thromboelastography (TEG) Machine Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Type (2021-2032)
- 6.2 Global Thromboelastography (TEG) Machine Revenue by Type (2021-2032)
- 6.2.1 Global Thromboelastography (TEG) Machine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Type (2021-2032)
- 6.3 Global Thromboelastography (TEG) Machine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Thromboelastography (TEG) Machine Sales by Application (2021-2032)
- 7.1.1 Global Thromboelastography (TEG) Machine Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Application (2021-2032)
- 7.2 Global Thromboelastography (TEG) Machine Revenue by Application (2021-2032)
- 7.2.1 Global Thromboelastography (TEG) Machine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Application (2021-2032)
- 7.3 Global Thromboelastography (TEG) Machine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Thromboelastography (TEG) Machine Value Chain Analysis
- 8.1.1 Thromboelastography (TEG) Machine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Thromboelastography (TEG) Machine Production Mode & Process
- 8.2 Thromboelastography (TEG) Machine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Thromboelastography (TEG) Machine Distributors
- 8.2.3 Thromboelastography (TEG) Machine Customers
9 Global Thromboelastography (TEG) Machine Analyzing Market Dynamics
- 9.1 Thromboelastography (TEG) Machine Industry Trends
- 9.2 Thromboelastography (TEG) Machine Industry Drivers
- 9.3 Thromboelastography (TEG) Machine Industry Opportunities and Challenges
- 9.4 Thromboelastography (TEG) Machine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst